RNA editing system based on CRISPR-Cas13 and application of RNA editing system
An RNA editing and editing technology, applied in the field of CRISPR-Cas13-based RNA editing system and gene editing, which can solve the problems of precise regulation without chemical modification and the inability to achieve precise time and space control of RNA editing.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment
[0059] Plasmid construction
[0060] Synthesized human codon-optimized CIBN and dCas13b (R146A / H151A / K385A / R394A) and cloned their fusion protein into pcDNA3.1 + The vector ensures that the open reading frame has no frame shift and mutation. Synthesize the fusion protein of human Mettl3 methylase domain (369-580 amino acids) and Mettl14 methylase domain (116-402 amino acids), and clone the fusion protein into pCRY2PHR-mCherryN1 (Addgene 26866), the restriction sites are SmaI and XbaI, which are the response elements of PAMEC-2; the full-length sequence of human FTO was synthesized and cloned into pCRY2PHR-mCherryN1 using the same strategy as above, which is the response element of PAMEC-1. The guide RNA was cloned into the Cas13bcrRNA backbone plasmid (Addgene 103853), and the restriction site was BbsI.
[0061] cell transfection
[0062] The present invention verified the effectiveness of the PAMEC system in Hela cells and mouse bone marrow mesenchymal stem cells. Hela cel...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com